title: Proteomic analysis of differential proteins in pancreatic carcinomas: Effects of MBD1 knock-down by stable RNA interference.
abstract: BACKGROUND
  Methyl-CpG binding domain protein 1 (MBD1), a suppressor of gene transcription, may be involved in inactivation of tumor suppressor genes during tumorigenesis. Over-expression of MBD1 has been reported in human pancreatic carcinomas.
  
  
  METHODS
  In this study, we established a MBD1-knock-down pancreatic cancer cell line (BxPC-3) using stable RNA interference, to compare the proteomic changes between control and MBD1-knock-down cells using two-dimensional gel electrophoresis and mass spectrometry.
  
  
  RESULTS
  We identified five proteins that were up-regulated and nine proteins that were down-regulated. Most of the identified proteins are involved in tumorigenesis, some are prognostic biomarkers for human malignant tumors.
  
  
  CONCLUSIONS
  Our data suggest that these differential proteins may be associated with the function of MBD1, and provide some insight into the functional mechanism of MBD1 in the development of pancreatic cancer.
authors.affiliation: Pancreatic Disease Institute, Department of General Surgery, Huashan Hospital, Fudan University, Shanghai 200040, PR China. blurlc@hotmail.com
authors.forename: Chen
authors.initials: C
authors.lastname: Liu
authors.forename: Yaohui
authors.initials: Y
authors.lastname: Chen
authors.forename: Xianjun
authors.initials: X
authors.lastname: Yu
authors.forename: Chen
authors.initials: C
authors.lastname: Jin
authors.forename: Jin
authors.initials: J
authors.lastname: Xu
authors.forename: Jiang
authors.initials: J
authors.lastname: Long
authors.forename: Quanxing
authors.initials: Q
authors.lastname: Ni
authors.forename: Deliang
authors.initials: D
authors.lastname: Fu
authors.forename: Hong
authors.initials: H
authors.lastname: Jin
authors.forename: Chen
authors.initials: C
authors.lastname: Bai
mesh_terms: D014408:Biomarkers, Tumor / Q000235:genetics; D045744:Cell Line, Tumor; D004268:DNA-Binding Proteins / Q000037:antagonists & inhibitors / Q000096:biosynthesis / Q000235:genetics*; D015180:Electrophoresis, Gel, Two-Dimensional; D020869:Gene Expression Profiling; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D010190:Pancreatic Neoplasms / Q000235:genetics* / Q000473:pathology; D040901:Proteomics; D034622:RNA Interference; D034741:RNA, Small Interfering / Q000008:administration & dosage / Q000235:genetics*; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; D014157:Transcription Factors / Q000037:antagonists & inhibitors / Q000096:biosynthesis / Q000235:genetics*
chemical_list: D014408:Biomarkers, Tumor; D004268:DNA-Binding Proteins; C066141:MBD1 protein, human; D034741:RNA, Small Interfering; D014157:Transcription Factors